Sonata Biosciences Inc
Auburn, CA · Biotech · Private
An electrophoresis-based peptide purification and concentration method for bottom-up proteomics workflows
- Grants
- $1.1M
- 4 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 2
- 0 granted · 2 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20152016201720182019
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Sample Pretreatment for Human Fluids | $199,832 | |
| Federal grant | Department of Health and Human Services · Phase I · Mining Complex Human Fluids for New Potential Protein Biomarkers | $300,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Bias-Free Peptide Preparation for Bottom-Up Proteomics | $300,020 | |
| Federal grant | Department of Health and Human Services · Phase I · Bias-Free Peptide Preparation for Bottom-Up Proteomics | $300,020 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2522 | Quantum Simulation Technologies, Inc. | — | $7.3M |
| 2523 | NeXtGen Biologics, INC | — | $2.9M |
| 2524 | ASSAYQUANT TECHNOLOGIES, INC. | — | $9.6M |
| 2525 | Sonata Biosciences Inc | — | — |
| 2526 | GENTEL BIOSCIENCES INC | — | $2.7M |
| 2527 | Insilico Medicine, Inc. | — | $20M |
| 2528 | Nuvectis Pharma, Inc. | — | $16M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Depletion of Abundant Serum Proteins to Facilitate Biomarker Discoveryapplication
- Depletion Of Abundant Serum Proteins To Facilitate Biomarker Discoveryapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.